Bierie, B. and H. L. Moses (2006). "Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer." Nat Rev Cancer 6(7): 506-20. 19. Blanchette, F., R. Day, et al. (1997). "TGFbeta1 regulates gene expression of its own converting enzyme furin." J Clin Invest 99(8): 1974-83. 20. Boczkowski, D., S. K. Nair, et al. ( 1996). "Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo." J Exp Med 184(2): 465-72. 21. Bodmer, S., K. Strommer, et al. (1989). "Immunosuppression and transforming growth factor-beta in glioblastoma. Pref erential production of transforming growth factor-beta 2." J Immunol 143(10): 3222-9. 22. Bommireddy, R. and T. D oetschman (2007). "TGFbeta1 and Treg cells: alliance for tolerance." Trends Mol Med 13(11): 492-501. 23. Border, W. A. and E. Ruoslahti (1992). "Transforming growth factor-beta in disease: the dark side of ti ssue repair." J Clin Invest 90(1): 1-7. 24. Braly, P., C. F. Nicodemus, et al . (2009). "The Immune adj uvant properties of front-line carboplatin-paclitaxel: a ran domized phase 2 study of alternative schedules of intravenous oregovom ab chemoimmunotherapy in advanced ovarian cancer." J Immunother 32(1): 54-65. 25.